Drug Profile
ODS 2004436
Alternative Names: 18F-ODS2004436; ODS-2004436Latest Information Update: 12 May 2021
Price :
$50
*
At a glance
- Originator Oncodesign Biotechnology
- Developer Centre Georges Francois Leclerc; Oncodesign Biotechnology
- Class Imaging agents; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-small cell lung cancer